Dr. Reddys Laboratories Ltd.

Dr Reddys Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a GMP inspection at its API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). They have been issued a Form 483 with 2 observations, which they will address within the stipulated timeline. 

The above information is a part of company’s filings submitted to BSE.